Evidence map›Paper›PMID 32533198›Full record

ArticleIntensive care medicine2020

Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection.

Nathalie Cardot-Leccia, Thomas Hubiche, Jean Dellamonica, Fanny Burel-Vandenbos, Thierry Passeron

Registry-linked trialAbstract readLetterComment
In one paragraph

Article in Intensive care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05669261 (A PILOT STUDY ON RESEARCH TREATMENT OF LONG COVID POST-ACUTE SEQUELAE OF SARS CoV-2 INFECTION), which is not on this map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05669261 phase1unknown statusnot on this mapstarted 2023, after this paper: background citation

A PILOT STUDY ON RESEARCH TREATMENT OF LONG COVID POST-ACUTE SEQUELAE OF SARS CoV-2 INFECTION ("PASC") USING ATCell™

TypeinterventionalSponsorAmerican CryoStem CorporationRan2023 to 2024Enrolled20ConditionsLong COVIDArmsAdipose Tissue Harvest, ATCell
3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Lung pericytes as mediators of inflammation.American journal of physiology. Lung cellular and molecular physiology · 2023
    Review
  14. Article
  15. Review
  16. Cardiac Pericytes: Underappreciated Targets of SARS-CoV-2.JACC. Basic to translational science · 2023
    Article
  17. Review
  18. Article
  19. Vascular inflammation in the central nervous system.Neural regeneration research · 2022
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Nathalie Cardot-LecciaDepartment of Pathology, Université Côte D'Azur. CHU Nice, Nice, France.
Thomas HubicheDepartment of Dermatology, Université Côte D'Azur. CHU Nice, Nice, France.
Jean DellamonicaMedical Intensive Care Unit, Université Côte D'Azur. UPR 01, UR2CA, CHU Nice, Nice, France.
Fanny Burel-VandenbosDepartment of Pathology, Université Côte D'Azur. CHU Nice, Nice, France.
Thierry PasseronDepartment of Dermatology, Université Côte D'Azur. CHU Nice, Nice, France. passeron@unice.fr.ORCID 0000-0002-0797-6570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronavirus InfectionsPandemicsPneumonia, ViralThrombosisBetacoronavirusCOVID-19HumansPericytesSARS-CoV-2

Identifiers

PMID32533198
PMCPMC7291173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.